Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
7.66
0.36 (4.93%)
At close: Aug 15, 2025, 3:59 PM
7.66
0.00%
After-hours: Aug 15, 2025, 04:11 PM EDT
Xeris Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 246.03M | 222.55M | 203.07M | 187.36M | 181.41M | 171.36M | 163.91M | 152.67M | 134.07M | 121.37M | 110.25M | 98.53M | 79.84M | 63.44M | 49.42M | 35.08M | 33.49M | 26.61M |
Cost of Revenue | 40.53M | 42.3M | 39.54M | 40.34M | 34.95M | 32.01M | 31.36M | 27.37M | 24.43M | 21.68M | 22.63M | 21.23M | 19.19M | 17.77M | 13.32M | 11.84M | 11.45M | 9.36M |
Gross Profit | 91.3M | 180.25M | 163.53M | 147.02M | 146.46M | 139.35M | 132.56M | 125.3M | 109.65M | 99.69M | 87.61M | 77.3M | 60.65M | 45.68M | 36.1M | 23.25M | 22.05M | 17.25M |
Operating Income | -9.82M | -22.49M | -33.65M | -45.17M | -37.19M | -44.98M | -44.01M | -49.34M | -63.21M | -66.14M | -81.94M | -115.04M | -120.62M | -127.49M | -115.16M | -86.23M | -75.61M | -72.03M |
Interest Income | 2.11M | 4.57M | 5.32M | 5.52M | 5.44M | 5.37M | 4.75M | 5.49M | 4.84M | 3.81M | 2.58M | 805K | 399K | 281K | 313K | 2.27M | 2.43M | 2.63M |
Pretax Income | -35.32M | -47.65M | -57.1M | -65.62M | -59.08M | -65.34M | -63.5M | -63.15M | -72.79M | -78.8M | -96.08M | -133.61M | -137.44M | -138.44M | -122.72M | -93.79M | -83.78M | -80.48M |
Net Income | -32M | -45.08M | -54.84M | -63.11M | -59.56M | -64.4M | -62.26M | -61.8M | -71.44M | -77.78M | -94.66M | -132.52M | -136.7M | -138.03M | -122.72M | -93.79M | -83.78M | -80.37M |
Selling & General & Admin | 173.52M | 169.12M | 163.48M | 160.91M | 153.23M | 150.87M | 146.09M | 142.88M | 140.09M | 135.44M | 137.75M | 157.57M | 149.61M | 142.55M | 125.72M | 89.54M | 79.49M | 71.2M |
Research & Development | 27.79M | 25.49M | 25.56M | 25.85M | 25M | 25.32M | 22.34M | 20.91M | 21.92M | 19.55M | 20.97M | 26.09M | 25.71M | 27.38M | 25.16M | 20.19M | 18.4M | 18.31M |
Other Expenses | 14.01M | 8.13M | 8.13M | 5.42M | -4.9M | -9.44M | -15.71M | -13M | -8.77M | -1.53M | 4.74M | 2.03M | 5.4M | 2.69M | -25K | -25K | n/a | n/a |
Operating Expenses | 215.32M | 202.74M | 197.17M | 192.18M | 180.94M | 181.62M | 173.86M | 171.93M | 172.85M | 165.83M | 169.55M | 192.34M | 181.27M | 173.17M | 151.26M | 109.47M | 97.66M | 89.28M |
Interest Expense | 15.49M | 30.76M | 30.48M | 29.8M | 28.86M | 27.43M | 26.61M | 23.96M | 21.1M | 18.02M | 15.32M | 12.75M | 10.56M | 8.91M | 7.18M | 9.97M | 10.51M | 10.95M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 255.85M | 245.04M | 236.72M | 232.53M | 218.6M | 216.33M | 207.92M | 202.01M | 197.28M | 187.51M | 192.19M | 213.57M | 200.46M | 190.93M | 164.58M | 121.31M | 109.11M | 98.65M |
Income Tax Expense | -3.32M | -2.58M | -2.27M | -2.5M | 1.16M | -266K | -573K | -675K | -1.35M | -1.02M | -1.42M | -1.09M | -747K | -408K | n/a | n/a | n/a | -110K |
Shares Outstanding (Basic) | 155.97M | 152.45M | 149.09M | 148.99M | 148.35M | 140.51M | 138.12M | 138.06M | 137.34M | 137.14M | 135.99M | 135.95M | 135.53M | 135.03M | 121.72M | 66.5M | 66.37M | 61.25M |
Shares Outstanding (Diluted) | 155.97M | 152.45M | 149.09M | 148.99M | 148.35M | 140.51M | 138.12M | 138.06M | 137.34M | 137.14M | 135.99M | 135.95M | 135.53M | 135.03M | 121.94M | 66.5M | 66.37M | 61.25M |
EPS (Basic) | -0.21 | -0.3 | -0.38 | -0.45 | -0.43 | -0.47 | -0.45 | -0.44 | -0.52 | -0.57 | -0.7 | -1.02 | -1.25 | -1.47 | -1.52 | -1.51 | -1.47 | -1.69 |
EPS (Diluted) | -0.21 | -0.3 | -0.38 | -0.45 | -0.43 | -0.47 | -0.45 | -0.44 | -0.52 | -0.57 | -0.7 | -1.02 | -1.25 | -1.47 | -1.52 | -1.51 | -1.47 | -1.69 |
EBITDA | 138K | -4.34M | -13.99M | -23.07M | -17.24M | -24.73M | -23.73M | -25.78M | -38.57M | -47.96M | -68.09M | -110.79M | -119.57M | -124.95M | -113.67M | -82.47M | -71.87M | -68.36M |
EBIT | -10.6M | -16.89M | -26.62M | -35.82M | -30.22M | -37.92M | -36.9M | -39.19M | -51.69M | -60.78M | -80.76M | -120.85M | -126.88M | -129.53M | -115.55M | -83.82M | -73.28M | -69.53M |
Depreciation & Amortization | 6.26M | 12.55M | 12.63M | 12.75M | 12.98M | 13.19M | 13.16M | 13.4M | 13.12M | 12.82M | 12.67M | 10.06M | 7.32M | 4.57M | 1.88M | 1.43M | 1.49M | 1.48M |